Revisiting Wilms tumour surveillance in Beckwith-Wiedemann syndrome with IC2 methylation loss, reply

Affiliations

¹ Sorbonne Université, INSERM UMR_S938 Centre de Recherche Saint-Antoine, AP-HP, Hôpital Trousseau, F-75012, Paris, France. frederic.brioude@aphp.fr.
² Department of Pediatrics, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
³ Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
⁴ Aix-Marseille Univ, Assistance Publique Hôpitaux de Marseille (APHM), Hôpital d'Enfants de La Timone, Service d'Hématologie-Oncologie Pédiatrique, Marseille, France.
⁵ Institute of Human Genetics, University Hospital, Technical University of Aachen, Aachen, Germany.
⁶ Department of Public Health and Pediatric Sciences, University of Torino, Torino, Italy.
⁷ Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
⁸ Sorbonne Université, INSERM UMR_S938 Centre de Recherche Saint-Antoine, AP-HP, Hôpital Trousseau, F-75012, Paris, France.
⁹ Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
¹⁰ Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK.
¹¹ Neonatal Intensive Care Unit, Department of Gynaecology and Obstetrics, S.Anna Hospital, Città della Salute e della Scienza di Torino, Torino, Italy.

Comment

Frédéric Brioude et al. Eur J Hum Genet. 2018 Apr.

. 2018 Apr;26(4):471-472.

doi: 10.1038/s41431-017-0074-2. Epub 2018 Feb 15.

¹ Sorbonne Université, INSERM UMR_S938 Centre de Recherche Saint-Antoine, AP-HP, Hôpital Trousseau, F-75012, Paris, France. frederic.brioude@aphp.fr.
² Department of Pediatrics, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
³ Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
⁴ Aix-Marseille Univ, Assistance Publique Hôpitaux de Marseille (APHM), Hôpital d'Enfants de La Timone, Service d'Hématologie-Oncologie Pédiatrique, Marseille, France.
⁵ Institute of Human Genetics, University Hospital, Technical University of Aachen, Aachen, Germany.
⁶ Department of Public Health and Pediatric Sciences, University of Torino, Torino, Italy.
⁷ Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
⁸ Sorbonne Université, INSERM UMR_S938 Centre de Recherche Saint-Antoine, AP-HP, Hôpital Trousseau, F-75012, Paris, France.
⁹ Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
¹⁰ Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK.
¹¹ Neonatal Intensive Care Unit, Department of Gynaecology and Obstetrics, S.Anna Hospital, Città della Salute e della Scienza di Torino, Torino, Italy.

No abstract available

Comment in

Reply to Brioude et al.
Brzezinski J, Shuman C, Choufani S, Ray P, Stavropoulos DJ, Basran R, Steele L, Parkinson N, Grant R, Thorner P, Lorenzo A, Weksberg R. Brzezinski J, et al. Eur J Hum Genet. 2018 Apr;26(4):473-474. doi: 10.1038/s41431-017-0094-y. Epub 2018 Feb 15. Eur J Hum Genet. 2018. PMID: 29449717 Free PMC article. No abstract available.

Wilms tumour in Beckwith-Wiedemann Syndrome and loss of methylation at imprinting centre 2: revisiting tumour surveillance guidelines.
Brzezinski J, Shuman C, Choufani S, Ray P, Stavropoulos DJ, Basran R, Steele L, Parkinson N, Grant R, Thorner P, Lorenzo A, Weksberg R. Brzezinski J, et al. Eur J Hum Genet. 2017 Sep;25(9):1031-1039. doi: 10.1038/ejhg.2017.102. Epub 2017 Jul 12. Eur J Hum Genet. 2017. PMID: 28699632 Free PMC article.

1. Brzezinski J, Shuman C, Choufani S, et al. Wilms tumour in Beckwith-Wiedemann syndrome and loss of methylation at imprinting centre 2: revisiting tumour surveillance guidelines. Eur J Hum Genet. 2017. 10.1038/ejhg.2017 - PMC - PubMed
1. Maas SM, Vansenne F, Kadouch DJ, et al. Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on the molecular genetic subgroups. Am J Med Genet Part A. 2016;170:2248–60. doi: 10.1002/ajmg.a.37801. - DOI - PubMed
1. Brioude F, Kalish JM, Mussa A, et al. Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement. Nat Rev Endocrinol. 2018 Jan 29. doi: 10.1038/nrendo.2017.166. - PMC - PubMed
1. Keren B, Chantot-Bastaraud S, Brioude F, et al. SNP arrays in Beckwith-Wiedemann syndrome: an improved diagnostic strategy. Eur J Med Genet. 2013;56:546–50. doi: 10.1016/j.ejmg.2013.06.005. - DOI - PubMed
1. Mussa A, Peruzzi L, Chiesa N, et al. Nephrological findings and genotype-phenotype correlation in Beckwith-Wiedemann syndrome. Pediatr Nephrol. 2012;27:397–406. doi: 10.1007/s00467-011-2009-4. - DOI - PubMed